JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Share Price
Equities
301093
CNE100004YH2
Tires & Rubber Products
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.28 CNY | -8.16% |
|
-8.58% | -31.02% |
| Sales 2024 * | 1.11B 153M 12.24B | Sales 2025 * | 1.57B 217M 17.37B | Capitalization | 2.88B 397M 31.82B |
|---|---|---|---|---|---|
| Net income 2024 * | 182M 25.12M 2.01B | Net income 2025 * | 283M 39.06M 3.13B | EV / Sales 2024 * | 2.6 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.83 x |
| P/E ratio 2024 * |
16.5
x | P/E ratio 2025 * |
10.6
x | Employees | 877 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.14% |
More Fundamentals
* Assessed data
More news
| 1 day | -8.16% | ||
| 1 week | -8.58% | ||
| Current month | -12.97% | ||
| 1 month | -10.52% | ||
| 3 months | -22.75% | ||
| 6 months | -35.46% | ||
| Current year | -31.02% |
1 week
21.79
24.75
1 month
21.7926.10
Current year
21.5032.54
1 year
21.5036.59
3 years
21.5057.88
5 years
21.5057.88
10 years
21.5057.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Min Hua
CEO | Chief Executive Officer | 42 | 31/12/08 |
Li Zhong Xu
DFI | Director of Finance/CFO | 51 | 31/05/19 |
Feng Xiao
BRD | Director/Board Member | 61 | 31/12/97 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zuo Jun Xu
BRD | Director/Board Member | 53 | 21/03/22 |
Wei Guo Ma
BRD | Director/Board Member | 55 | 31/12/97 |
Li Liu
BRD | Director/Board Member | 45 | 21/03/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 22.28 | -8.16% | 7,886,548 |
| 25/04/24 | 24.26 | -0.41% | 1,180,937 |
| 24/04/24 | 24.36 | +1.00% | 789,600 |
| 23/04/24 | 24.12 | -1.11% | 1,124,063 |
| 22/04/24 | 24.39 | +0.08% | 1,165,658 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Jiangsu Hualan New Pharmaceutical Material Co Ltd is a China-based company primarily engaged in the research, development, production and sales of packaging materials for direct contact injection drugs. The Companyâs main products include various kinds of coated rubber stoppers, conventional rubber stoppers and others. The Company's products are mainly used in the field of pharmaceutical preparations such as infusion, freeze-drying, powder injection, monoclonal antibodies, small water injections, blood sampling, and Chinese medicine compound preparations, among others. The Company also produces plastic infusion container assemblies and urinary anorectal minimally invasive surgical instruments. The Company distributes its products within the domestic market and to overseas markets, including Italy, Egypt, Saudi Arabia, Qatar and other areas.
Sector
Tires & Rubber Products
Calendar
13/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.28
CNY
Average target price
43.78
CNY
Spread / Average Target
+96.50%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -31.02% | 397M | |
| +15.15% | 29.25B | |
| +9.74% | 27.19B | |
| +40.43% | 7.18B | |
| +22.39% | 4.04B | |
| -17.32% | 3.36B | |
| +41.51% | 3.29B | |
| +20.79% | 3.09B | |
| +21.78% | 2.81B | |
| -3.24% | 2.24B |
- Stock Market
- Equities
- 301093 Stock
